These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10697121)

  • 1. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
    Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
    Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
    Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
    Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
    Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
    Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery.
    Magin-Lachmann C; Kotzamanis G; D'Aiuto L; Wagner E; Huxley C
    BMC Biotechnol; 2003 Feb; 3(1):2. PubMed ID: 12609052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
    Wendelburg BJ; Vos JM
    Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
    Otomo T; Yamamoto S; Morishita R; Kaneda Y
    J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
    Shan L; Wang L; Yin J; Zhong P; Zhong J
    J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
    Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
    J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
    Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
    Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
    Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
    J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
    Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
    Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells.
    Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O
    J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
    Sia KC; Chong WK; Ho IA; Yulyana Y; Endaya B; Huynh H; Lam PY
    J Gene Med; 2010 Oct; 12(10):848-58. PubMed ID: 20963807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome.
    Satoh E; Osawa M; Tomiyasu K; Hirai H; Shimazaki C; Oda Y; Nakagawa M; Kondo M; Kinoshita S; Mazda O; Imanishi J
    Biochem Biophys Res Commun; 1997 Sep; 238(3):795-9. PubMed ID: 9325170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells.
    Huertas D; Howe S; McGuigan A; Huxley C
    Hum Mol Genet; 2000 Mar; 9(4):617-29. PubMed ID: 10699185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.